Compounds > 5-methoxytryptamine
Page last updated: 2024-10-21

5-methoxytryptamine and Parkinsonian Disorders

5-methoxytryptamine has been researched along with Parkinsonian Disorders in 3 studies

5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Willis, GL3
Robertson, AD2

Trials

1 trial available for 5-methoxytryptamine and Parkinsonian Disorders

ArticleYear
Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23.
    Pharmacology, biochemistry, and behavior, 2005, Volume: 80, Issue:1

    Topics: 5-Methoxytryptamine; Animals; Behavior, Animal; Callithrix; Cross-Over Studies; Eating; Male; Melato

2005

Other Studies

2 other studies available for 5-methoxytryptamine and Parkinsonian Disorders

ArticleYear
Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 79, Issue:3

    Topics: 5-Methoxytryptamine; Animals; Male; Melatonin; Naphthalenes; Oxidopamine; Parkinsonian Disorders; Ra

2004
Intraocular microinjections repair experimental Parkinson's disease.
    Brain research, 2008, Jun-27, Volume: 1217

    Topics: 5-Methoxytryptamine; Animals; Antiparkinson Agents; Circadian Rhythm; Levodopa; Male; Microinjection

2008